Biofrontera Inc. (BFRI)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Biofrontera Inc. reported revenue of $41.70M, up 11.7% from the prior year. The company ran a net loss, with a net margin of -25.3%. It held $28.56M in total assets against $18.08M in total liabilities.
Key ratios (FY2025)
-27.2%
Operating margin
-25.3%
Net margin
-100.5%
Return on equity
+11.7%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $41.70M | $37.32M | $34.07M | $28.67M | $24.04M | $18.85M | — |
| Operating Income | -$11.35M | -$17.21M | -$22.68M | -$18.58M | -$25.20M | -$9.61M | — |
| Net Income | -$10.54M | -$17.76M | -$20.13M | -$640.0K | -$37.71M | -$10.99M | — |
| EPS (Diluted) | $-1.04 | $-3.22 | $-13.02 | $-0.61 | $-85.63 | — | — |
| Total Assets | $28.56M | $22.10M | $27.93M | $50.88M | $53.22M | $24.14M | — |
| Total Liabilities | $18.08M | $17.67M | $23.14M | $27.01M | $41.88M | $18.31M | — |
| Shareholders' Equity | $10.48M | $4.43M | $4.79M | $23.88M | $11.34M | $5.83M | -$30.18M |
| Cash & Equivalents | $6.39M | $5.91M | $1.34M | $17.21M | $24.55M | $8.08M | — |
| Operating Cash Flow | -$13.36M | -$10.27M | -$24.89M | -$16.20M | -$26.71M | -$12.37M | — |
| Capital Expenditures | $2.0K | $10.0K | $5.0K | $38.0K | — | — | — |
| Shares Outstanding | 11.65M | 8.87M | 1.52M | 1.33M | 855.2K | 8.00M | — |